MassDevice6d
Onward announces first human use of ARC-IM lumbar lead
Onward Medical announced today that a neurosurgeon performed the first human implant of its investigational ARC-IM lumbar ...
ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility
The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study The Company ...
Johns Hopkins Medicine1d
Experimental Blood Test Shown to Accurately Indicate Severity and Predict Potential Recovery From Spinal Cord Injury
New study in @jclinicalinvest by @HopkinsMedicine researchers suggests experimental blood test can indicate spinal cord ...
Nature6mon
Cord blood stem cells: worth the investment
McGuckin, C. et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200, 123–135 (2004). Article Google Scholar ...
TipRanks on MSN17d
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
ExoPTEN, which is advancing towards first-in-human trials. The study demonstrated that ExoPTEN significantly enhances motor function recovery and improves blood flow at spinal cord injury sites, ...
Fred Hutch4d
Cord Blood Transplant Program
Since its launch in 2006, our Cord Blood Transplant Program has performed nearly 500 transplants in patients with blood cancer and other diseases, ranging from 1 to 71 years old. Our investigators are ...